CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,963,590 | +22.2% | 1,283,303 | -0.2% | 0.01% | +40.0% |
| Q2 2023 | $28,605,068 | -2.3% | 1,285,621 | -4.9% | 0.01% | -16.7% |
| Q1 2023 | $29,275,526 | +40.7% | 1,351,594 | +31.9% | 0.01% | +50.0% |
| Q4 2022 | $20,806,905 | -18.6% | 1,024,466 | +2.7% | 0.00% | -33.3% |
| Q3 2022 | $25,572,000 | +7.8% | 997,317 | -0.0% | 0.01% | +20.0% |
| Q2 2022 | $23,720,000 | +1.5% | 997,493 | -3.9% | 0.01% | +25.0% |
| Q1 2022 | $23,376,000 | +4.3% | 1,037,963 | -8.3% | 0.00% | 0.0% |
| Q4 2021 | $22,422,000 | -3.8% | 1,132,462 | -4.4% | 0.00% | 0.0% |
| Q3 2021 | $23,307,000 | -12.4% | 1,184,257 | -2.1% | 0.00% | -20.0% |
| Q2 2021 | $26,616,000 | -10.1% | 1,209,833 | -2.8% | 0.01% | -16.7% |
| Q1 2021 | $29,613,000 | -13.3% | 1,244,752 | -4.7% | 0.01% | -14.3% |
| Q4 2020 | $34,167,000 | +47.2% | 1,306,061 | -2.1% | 0.01% | +40.0% |
| Q3 2020 | $23,213,000 | -1.7% | 1,333,744 | -5.0% | 0.01% | -16.7% |
| Q2 2020 | $23,624,000 | +51.6% | 1,404,587 | +7.1% | 0.01% | +50.0% |
| Q1 2020 | $15,588,000 | -0.2% | 1,311,018 | +1.5% | 0.00% | +33.3% |
| Q4 2019 | $15,624,000 | -14.9% | 1,291,300 | -0.5% | 0.00% | -25.0% |
| Q3 2019 | $18,354,000 | +27.4% | 1,298,416 | +0.5% | 0.00% | +33.3% |
| Q2 2019 | $14,406,000 | -4.2% | 1,291,993 | +0.8% | 0.00% | -25.0% |
| Q1 2019 | $15,040,000 | -13.6% | 1,281,168 | -1.6% | 0.00% | -20.0% |
| Q4 2018 | $17,401,000 | -5.4% | 1,302,480 | -0.7% | 0.01% | 0.0% |
| Q3 2018 | $18,387,000 | -6.2% | 1,311,436 | +5.1% | 0.01% | 0.0% |
| Q2 2018 | $19,610,000 | +6.8% | 1,247,442 | +11.7% | 0.01% | 0.0% |
| Q1 2018 | $18,368,000 | -8.5% | 1,116,603 | +0.5% | 0.01% | 0.0% |
| Q4 2017 | $20,069,000 | -6.2% | 1,111,261 | +0.3% | 0.01% | -16.7% |
| Q3 2017 | $21,388,000 | +66.6% | 1,108,222 | +1.9% | 0.01% | +50.0% |
| Q2 2017 | $12,838,000 | +26.9% | 1,087,927 | +17.8% | 0.00% | +33.3% |
| Q1 2017 | $10,117,000 | +60.0% | 923,195 | +6.0% | 0.00% | +50.0% |
| Q4 2016 | $6,323,000 | +13.6% | 870,921 | +1.7% | 0.00% | 0.0% |
| Q3 2016 | $5,566,000 | +21.9% | 856,298 | +2.4% | 0.00% | +100.0% |
| Q2 2016 | $4,567,000 | +36.6% | 836,369 | +17.1% | 0.00% | 0.0% |
| Q1 2016 | $3,343,000 | -3.3% | 714,414 | +2.9% | 0.00% | 0.0% |
| Q4 2015 | $3,457,000 | +35.9% | 694,220 | +2.6% | 0.00% | 0.0% |
| Q3 2015 | $2,543,000 | -29.6% | 676,530 | +12.6% | 0.00% | 0.0% |
| Q2 2015 | $3,610,000 | +10.2% | 600,661 | +2.6% | 0.00% | 0.0% |
| Q1 2015 | $3,277,000 | +90.4% | 585,183 | +2.0% | 0.00% | 0.0% |
| Q4 2014 | $1,721,000 | +7.0% | 573,701 | -4.5% | 0.00% | 0.0% |
| Q3 2014 | $1,609,000 | -5.1% | 600,576 | -0.9% | 0.00% | 0.0% |
| Q2 2014 | $1,696,000 | -40.7% | 605,872 | -7.7% | 0.00% | 0.0% |
| Q1 2014 | $2,861,000 | +25.0% | 656,126 | -7.9% | 0.00% | 0.0% |
| Q4 2013 | $2,288,000 | +105.9% | 712,624 | +1.9% | 0.00% | – |
| Q3 2013 | $1,111,000 | -1.9% | 699,027 | +6.7% | 0.00% | – |
| Q2 2013 | $1,133,000 | – | 654,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |